Recorded webinar

Understand and Mitigate Interface-Induced Risks in Biopharmaceutical Development with QSense QCM-D

In this webinar you will learn how QSense QCM-D can be used to investigate interface-related risks in biopharmaceutical development, from early developability through formulation and fill–finish.

Surface-induced processes such as adsorption, unfolding and aggregation at solid–liquid interfaces are increasingly recognized as potential contributors to subvisible particles (SVPs), long-term interfacial changes and material compatibility issues.

Webinar details

Originally aired
March 10th, 2026
Length
60 min
Presentation by
Fredrik Pettersson
Technologies
QCM-D

View on demand

In this webinar:

Overview: Interface-induced instabilities and whysurfaces matter in biopharma development

QSense QCM-D as a mechanistic tool for antibody–surface interaction and stability assessment

Case examples from recent publications

Presentation by Fredrik Pettersson

Fredrik Pettersson, Senior Application Scientist at Biolin Scientific, will show how nanoscale adsorption measurements using QSense QCM-D can help establish mechanistic links to macroscopic outcomes such as SVP formation, aggregation, and interfacial instability over time.